{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:23:52Z","timestamp":1790796232516,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s13730-019-00414-3","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T02:02:46Z","timestamp":1569204166000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A case of denosumab-associated membranous nephropathy in a patient with rheumatoid arthritis"],"prefix":"10.1007","volume":"9","author":[{"given":"Miyuki","family":"Kimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7935-3105","authenticated-orcid":false,"given":"Naoya","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahomi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misaki","family":"Maruo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"key":"414_CR1","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s10157-012-0593-7","volume":"16","author":"H Yokoyama","year":"2012","unstructured":"Yokoyama H, Taguchi T, Sugiyama H, et al. Membranous nephropathy in Japan: analysis of the Japan Renal Biopsy Registry (J-RBR). Clin Exp Nephrol. 2012;16:557\u201363.","journal-title":"Clin Exp Nephrol"},{"key":"414_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1681\/ASN.2004121080","volume":"16","author":"P Ronco","year":"2005","unstructured":"Ronco P, Debiec H. Molecular pathomechanisms of membranous nephropathy: from Heymann nephritis to alloimmunization. J Am Soc Nephrol. 2005;16:1205\u201313.","journal-title":"J Am Soc Nephrol"},{"key":"414_CR3","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.ajkd.2013.03.045","volume":"62","author":"FA Nawaz","year":"2013","unstructured":"Nawaz FA, Larsen CP, Troxell ML. Membranous nephropathy and nonsteroidal anti-inflammatory agents. Am J Kidney Dis. 2013;62:1012\u20137.","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 1","key":"414_CR4","first-page":"64","volume":"7","author":"RJ Glassock","year":"1992","unstructured":"Glassock RJ. Secondary membranous glomerulonephritis. Nephrol Dial Transplant. 1992;7(Suppl 1):64\u201371.","journal-title":"Nephrol Dial Transplant"},{"key":"414_CR5","first-page":"397","volume":"27","author":"Z Rihova","year":"2005","unstructured":"Rihova Z, Honsova E, Merta M, et al. Secondary membranous nephropathy\u2014one center experience. Ren Fail. 2005;27:397\u2013402.","journal-title":"Ren Fail"},{"key":"414_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature. 2003;423:337\u201342.","journal-title":"Nature"},{"key":"414_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jocd.2008.02.002","volume":"11","author":"PD Delmas","year":"2008","unstructured":"Delmas PD. Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases. J Clin Densitom. 2008;11:325\u201338.","journal-title":"J Clin Densitom"},{"key":"414_CR8","doi-asserted-by":"publisher","first-page":"e0197984","DOI":"10.1371\/journal.pone.0197984","volume":"13","author":"Q Chen","year":"2018","unstructured":"Chen Q, Hu C, Liu Y, et al. Pharmacokinetics, pharmacodynamics, safety, and tolerability of single-dose denosumab in healthy Chinese volunteers: a randomized, single-blind, placebo-controlled study. PLoS One. 2018;13:e0197984.","journal-title":"PLoS One"},{"key":"414_CR9","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.jcms.2018.05.046","volume":"46","author":"S Aljohani","year":"2018","unstructured":"Aljohani S, Gaudin R, Weiser J, et al. Osteonecrosis of the jaw in patients treated with denosumab: a multicenter case series. J Craniomaxillofac Surg. 2018;46:1515\u201325.","journal-title":"J Craniomaxillofac Surg"},{"key":"414_CR10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.2215\/CJN.01910215","volume":"10","author":"JJ Hogan","year":"2015","unstructured":"Hogan JJ, Markowitz GS, Radhakrishnan J. Drug-induced glomerular disease: immune-mediated injury. Clin J Am Soc Nephrol. 2015;10:1300\u201310.","journal-title":"Clin J Am Soc Nephrol"},{"key":"414_CR11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s10157-015-1201-4","volume":"20","author":"H Yokoyama","year":"2016","unstructured":"Yokoyama H, Narita I, Sugiyama H, et al. Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015. Clin Exp Nephrol. 2016;20:720\u201330.","journal-title":"Clin Exp Nephrol"},{"key":"414_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature. 1997;390:175\u20139.","journal-title":"Nature"},{"key":"414_CR13","doi-asserted-by":"publisher","first-page":"e41331","DOI":"10.1371\/journal.pone.0041331","volume":"7","author":"S Liu","year":"2012","unstructured":"Liu S, Shi W, Xiao H, et al. Receptor activator of NF-kappa B and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury. PLoS One. 2012;7:e41331.","journal-title":"PLoS One"},{"key":"414_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck","year":"2009","unstructured":"Beck LH, Bonegio RG, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11\u201321.","journal-title":"N Engl J Med"},{"key":"414_CR15","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s10157-014-1054-2","volume":"19","author":"S Akiyama","year":"2015","unstructured":"Akiyama S, Akiyama M, Imai E, et al. Prevalence of anti-phospholipase A2 receptor antibodies in Japanese patients with membranous nephropathy. Clin Exp Nephrol. 2015;19:653\u201360.","journal-title":"Clin Exp Nephrol"},{"key":"414_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s10157-014-1064-0","volume":"19","author":"N Hayashi","year":"2015","unstructured":"Hayashi N, Akiyama S, Okuyama H, et al. Clinicopathological characteristics of M-type phospholipase A2 receptor (PLA2R)-related membranous nephropathy in Japanese. Clin Exp Nephrol. 2015;19:797\u2013803.","journal-title":"Clin Exp Nephrol"},{"key":"414_CR17","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/ki.1997.32","volume":"51","author":"H Imai","year":"1997","unstructured":"Imai H, Hamai K, Komatsuda A, et al. IgG subclasses in patients with membranoproliferative glomerulonephritis, membranous nephropathy, and lupus nephritis. Kidney Int. 1997;51:270\u20136.","journal-title":"Kidney Int"},{"key":"414_CR18","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1053\/ajkd.2002.31987","volume":"39","author":"K Nagahama","year":"2002","unstructured":"Nagahama K, Matsushita H, Hara M, et al. Bucillamine induces membranous glomerulonephritis. Am J Kidney Dis. 2002;39:706\u201312.","journal-title":"Am J Kidney Dis"},{"key":"414_CR19","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ndt\/gfg616","volume":"19","author":"H Ohtani","year":"2004","unstructured":"Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant. 2004;19:574\u20139.","journal-title":"Nephrol Dial Transplant"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-019-00414-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-019-00414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T23:25:34Z","timestamp":1600730734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-019-00414-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["414"],"URL":"https:\/\/doi.org\/10.1007\/s13730-019-00414-3","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,23]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors have declared that they have no competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}